By contrast, CD39+CD3+CD45+ (p = 0.0004), CD39+CD4+CD3+CD45+ (p = 0.016), and CD39+CD8+CD3+CD45+ (p = 0.0089) cells were significantly increased in COVID-19 patients. This evidence concerns the gene PTPRC and COVID-19.